It is great that you included photographs of the horrors. These horrors should be seen for what they are, and not merely referred euphemistically as "bottom surgeries."
A couple of related points. When the Times published their long article on puberty blockers, "They Paused Puberty, but Is There a Cost?", one of the people who wrote a letter to the Times was Mark Garnick (se his profile here: https://www.dfhcc.harvard.edu/insider/member-detail/member/marc-b-garnick-md/), "one of three academic principal clinical investigators of studies that led to the initial F.D.A. approval of Lupron for the treatment of metastatic prostate cancer," as he wrote in his letter (https://www.nytimes.com/2022/11/28/opinion/letters/puberty-blockers-transgender-youths.html). He went on to state: "...having studied this class of drugs, which includes puberty blockers, for more than four decades...I can say that physicians are still learning and continue to be concerned about the safety of these agents in adults...Woefully little safety data are available for the likely more vulnerable younger population. Bone loss in adult men who have been on these agents is significant, and a leading cause of morbidity with long-term administration...Other safety issues include cognitive, metabolic and cardiovascular effects, still under intense investigation. The prudent and ethical use of such agents in the younger population should demand that every pubertal or pre-pubertal child be part of rigorous clinical research studies that evaluate both the short-term and longer-term effects of these agents to better define the true risks and benefits rather than relying on anecdotal information."
Also, reading the account of Abel Garcia, I was reminded of my conversation with a 70-year-old male detransitioner, and I put it up here: https://mungeribabu.substack.com/p/my-conversation-with-hank. He too is in the process of losing his eyesight in one eye. With the other, he has had repeated retinal detachments. And he mentioned that he knows several MtF detransitioners who suffer from the same problem - retinal detachment. And the list of diseases he suffers from! Several heart attacks (the first one before 40), hypertension, rheumatoid arthritis, scleroderma, low back pain, allergies, asthma, retinal detachment in one eye and loss of sight in another, and a cocktail of medication for his heart. He has had stones in his liver ("the doctors had never seen anything like that"), kidney, gallbladder, and saliva ducts ("the size of lime pits, and they had to operate inside my mouth to get them out.").
It might be very instructive if you can find OLDER transgender people who can narrate all the various things they suffer from after the hormones and surgery. It can be a very instructive series.
It is great that you included photographs of the horrors. These horrors should be seen for what they are, and not merely referred euphemistically as "bottom surgeries."
A couple of related points. When the Times published their long article on puberty blockers, "They Paused Puberty, but Is There a Cost?", one of the people who wrote a letter to the Times was Mark Garnick (se his profile here: https://www.dfhcc.harvard.edu/insider/member-detail/member/marc-b-garnick-md/), "one of three academic principal clinical investigators of studies that led to the initial F.D.A. approval of Lupron for the treatment of metastatic prostate cancer," as he wrote in his letter (https://www.nytimes.com/2022/11/28/opinion/letters/puberty-blockers-transgender-youths.html). He went on to state: "...having studied this class of drugs, which includes puberty blockers, for more than four decades...I can say that physicians are still learning and continue to be concerned about the safety of these agents in adults...Woefully little safety data are available for the likely more vulnerable younger population. Bone loss in adult men who have been on these agents is significant, and a leading cause of morbidity with long-term administration...Other safety issues include cognitive, metabolic and cardiovascular effects, still under intense investigation. The prudent and ethical use of such agents in the younger population should demand that every pubertal or pre-pubertal child be part of rigorous clinical research studies that evaluate both the short-term and longer-term effects of these agents to better define the true risks and benefits rather than relying on anecdotal information."
Also, reading the account of Abel Garcia, I was reminded of my conversation with a 70-year-old male detransitioner, and I put it up here: https://mungeribabu.substack.com/p/my-conversation-with-hank. He too is in the process of losing his eyesight in one eye. With the other, he has had repeated retinal detachments. And he mentioned that he knows several MtF detransitioners who suffer from the same problem - retinal detachment. And the list of diseases he suffers from! Several heart attacks (the first one before 40), hypertension, rheumatoid arthritis, scleroderma, low back pain, allergies, asthma, retinal detachment in one eye and loss of sight in another, and a cocktail of medication for his heart. He has had stones in his liver ("the doctors had never seen anything like that"), kidney, gallbladder, and saliva ducts ("the size of lime pits, and they had to operate inside my mouth to get them out.").
It might be very instructive if you can find OLDER transgender people who can narrate all the various things they suffer from after the hormones and surgery. It can be a very instructive series.
And here is the issues with estrogen in men I found in the peer-reviewed literature: https://mungeribabu.substack.com/p/estrogen-is-really-bad-for-men.
Thank you for what you are doing.